Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Enrollment and dosing begin in first-in-human AT-001 trial

Aug. 24, 2012

OXiGENE and Azanta expand Zybrestat agreement

Aug. 23, 2012

Kyowa Hakko Kirin launches pivotal mogamulizumab trial

Aug. 23, 2012

Novel candidate anticancer drugs synthesized in U.S.

Aug. 23, 2012

U.S. university develops new anticancer products

Aug. 23, 2012

Takeda presents new potent IAP inhibitors with promising oncolytic activity

Aug. 23, 2012

Research collaboration begins for delivery of microRNA-based therapeutics

Aug. 22, 2012

NICE issues new guidance on bevacizumab

Aug. 22, 2012

Novel tyrosine kinase inhibitors patented by Pierre Fabre Medicament

Aug. 22, 2012

New pim-1/2 inhibitors developed

Aug. 22, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...